# The Research of Standard Diagnosis and Treatment for HSPN in Children

> **NCT02532777** · PHASE2 · UNKNOWN · sponsor: **Nanjing Children's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Henoch-Schoenlein Purpura Nephritis

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Cyclophosphamide(CTX)
- **DRUG:** Mycophenolate mofetil(MMF)
- **DRUG:** Leflunomide(LEF)
- **DRUG:** Angiotensin-converting enzyme inhibitor(ACEI)
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT02532777
- **Lead sponsor:** Nanjing Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532777, "The Research of Standard Diagnosis and Treatment for HSPN in Children". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02532777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*